袖状胃切除与胃旁路术后长期体重变化及健康结局比较
SG组多为高危或超肥胖且计划二期手术者,术后1至7年减重显著少于RYGB组,7年平均减重23.6%对30.4%(P=.001);两组术后5年糖尿病、低HDL及高血压患病率较基线均显著降低(P<.05)。
要点
- SG组多为高危或超肥胖且拟行二期手术者,7年减重少于配对RYGB组。
- 7年平均减重SG为23.6%、RYGB为30.4%(P=.001)。
- 两组术后5年糖尿病、低HDL和高血压患病率均较基线显著改善。
核心结论
- 高危或超肥胖患者行SG后7年内减重持续少于配对RYGB患者,但两组5年内合并症均有改善。
研究设计与样本
- SG组为高危或超肥胖且拟行二期手术者。
主要发现
- SG组术后1至7年减重显著少于配对RYGB组,第7年平均减重23.6%对30.4%(P=.001)。
- 两组术后5年糖尿病、低HDL和高血压患病率均较术前基线显著降低(P<.05)。
临床怎么用
- 对高危或超肥胖拟行SG者应预期其减重幅度可能低于RYGB,并重视5年内合并症随访管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Data from a US multicenter longitudinal study of bariatric surgery were used to compare weight change (primary outcome) and comorbidities (secondary outcome) in patients who underwent sleeve gastrectomy versus Roux-en-Y gastric bypass. METHODS: This study includes participants who underwent sleeve gastrectomy and matched participants who underwent Roux-en-Y gastric bypass from the Longitudinal Assessment of Bariatric Surgery-2 (LABS-2) study. Adults undergoing initial bariatric surgical procedures between 2006 and 2009 were enrolled. Participants who underwent sleeve gastrectomy were high-risk or superobese and intended to have a second-stage procedure. Mixed models were used to evaluate percent weight change from baseline through 7 years, and diabetes, dyslipidemia, and hypertension prevalence through 5 years. RESULTS: Fifty-seven of 59 participants who underwent sleeve gastrectomy were matched one to one. Most were female (68%) and white (81%), and had a median age of 49 (37-56) years and median body mass index of 56.4 (35.5-76.8) kg/m2 presurgery. Weight loss was significantly less 1 to 7 years after sleeve gastrectomy versus matched Roux-en-Y gastric bypass (eg, year 7 mean weight loss was 23.6% vs 30.4%, respectively; P = .001). For both surgical groups, prevalence of diabetes, low high-density lipoprotein, and hypertension were significantly (P < .05) lower 5 years postsurgery versus baseline. CONCLUSION: Higher-risk or super-obese participants after sleeve gastrectomy lost less weight than did matched Roux-en-Y gastric bypass counterparts throughout 7 years. Both groups exhibited improvements in comorbidities from presurgery through 5 years.
引用
- Ahmed B, King WC, Gourash W, et al. Long-term weight change and health outcomes for sleeve gastrectomy (SG) and matched Roux-en-Y gastric bypass (RYGB) participants in the Longitudinal Assessment of Bariatric Surgery (LABS) study. Surgery. 2018. PMID: 30139560. doi:10.1016/j.surg.2018.06.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。